Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R de Waart

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|April 12, 1994
Studies on the urinary excretion of thromboxane B2 in Zellweger patients and control subjects: evidence for a major role for peroxisomes in the beta-oxidative chain-shortening of thromboxane B2D R de Waart, G C Koomen, R J Wanders
Biochemical and Biophysical Research Communications|September 11, 2001
Biliary anionic peptide fraction/calcium binding protein inhibits apolipoprotein A-I-mediated cholesterol efflux from cultured cellsM J van Wijland, D R de Waart, A K Groen
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 16, 2000
Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysisW Smit, D R de Waart, D G Struijk, et al.
The Journal of Laboratory and Clinical Medicine|October 30, 1998
Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?C E Douma, D R de Waart, D G Struijk, et al.
Kidney International|June 1, 1997
The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPDC E Douma, D R de Waart, D G Struijk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 28, 2001
Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolalityD R de Waart, M M Zweers, D G Struijk, et al.
Clinical Nephrology|May 1, 1996
Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?C E Douma, D R de Waart, D G Struijk, et al.
Toxicology and Applied Pharmacology|February 13, 2001
Lack of UGT1 isoforms in Gunn rats changes metabolic ratio and facilitates excretion of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazoC G Dietrich, R Ottenhoff, D R de Waart, et al.
Toxicology|September 15, 2001
Role of MRP2 and GSH in intrahepatic cycling of toxinsC G Dietrich, R Ottenhoff, D R de Waart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2001
Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPDC E Douma, D R de Waart, D Zemel, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|April 12, 1994
Studies on the urinary excretion of thromboxane B2 in Zellweger patients and control subjects: evidence for a major role for peroxisomes in the beta-oxidative chain-shortening of thromboxane B2D R de Waart, G C Koomen, R J Wanders
Biochemical and Biophysical Research Communications|September 11, 2001
Biliary anionic peptide fraction/calcium binding protein inhibits apolipoprotein A-I-mediated cholesterol efflux from cultured cellsM J van Wijland, D R de Waart, A K Groen
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 16, 2000
Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysisW Smit, D R de Waart, D G Struijk, et al.
The Journal of Laboratory and Clinical Medicine|October 30, 1998
Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?C E Douma, D R de Waart, D G Struijk, et al.
Kidney International|June 1, 1997
The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPDC E Douma, D R de Waart, D G Struijk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 28, 2001
Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolalityD R de Waart, M M Zweers, D G Struijk, et al.
Clinical Nephrology|May 1, 1996
Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?C E Douma, D R de Waart, D G Struijk, et al.
Toxicology and Applied Pharmacology|February 13, 2001
Lack of UGT1 isoforms in Gunn rats changes metabolic ratio and facilitates excretion of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazoC G Dietrich, R Ottenhoff, D R de Waart, et al.
Toxicology|September 15, 2001
Role of MRP2 and GSH in intrahepatic cycling of toxinsC G Dietrich, R Ottenhoff, D R de Waart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2001
Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPDC E Douma, D R de Waart, D Zemel, et al.
Pageof 3